NMDA antagonist for traumatic brain injury (Eumentis)

N/A

Report date: 2024/07/26 17:43:36
NME

Base Information

Drug NameNMDA antagonist for traumatic brain injury (Eumentis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEumentis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEumentis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A